Teva Pharmaceuticals
Allergan to sell US distribution unit Anda to Teva for $500 mn
04 Aug 2016
The sale comes just a day after Teva completed its $40.5-billion acquisition of Allergan’s generic unit, following US regulatory approval a week ago
European regulator approves Teva’s $40.5-bn Allergan drug unit deal with conditions
11 Mar 2016
The European Commission yesterday approved Teva Pharmaceutical Industries' $40.5-billion acquisition of the generics drug unit of Allergan on condition that it divests some Allergan products in the UK and Ireland
Teva to buy Mexican drugmaker Rimsa for $2.3 bn
03 Oct 2015
With this acquisition, Teva will become a leading pharmaceutical company in Mexico, the second-largest market in Latin America and one of the top five emerging markets globally
Teva in $40.5-bn pact to buy Allergan's generics, ends Mylan bid
27 Jul 2015
Post-merger, Allergan will have one of the broadest product portfolios and strongest pipelines in the generics industry
Teva in talks to buy Allergan's generic-drug unit for $45 bn: report
27 Jul 2015
A deal with Allergan would indicate that Teva could be considering abandoning its plan to buy Mylan NV after the Netherlands-based company rejected its $40-billion takeover offer
Teva plans to raise bid for rival drugmaker Mylan to $42 bn
07 Jul 2015
Teva and Mylan's product offerings are highly complementary and, together, would create the broadest portfolio in the global pharmaceuticals industry, with a combined pipeline of over 400 applications for new drugs
Teva pressures takeover target Mylan with 1.8% stake buy
03 Jun 2015
Analysts expect Teva to make a sweetened formal bid for Mylan after raising its stake to the 4.6 per cent threshold, because once it tables a formal bid, it cannot buy Mylan shares from the market
Teva settles US antitrust charges for $1.2 bn
29 May 2015
The world’s biggest generic drug maker Israel’s Teva Pharmaceutical Industries has agreed to settle US antitrust charges for illegally blocking competition to its blockbuster sleep-disorder drug Provigil
Teva Pharmaceutical offers to buy Mylan NV for $40 bn
22 Apr 2015
A successful Teva-Mylan merger would be the largest in the pharmaceutical industry this year, which has seen acquisitions taking place at a frenzied pace
Teva Pharmaceutical to buy US neurology drug firm Auspex $3.5 bn
31 Mar 2015
Auspex is a biopharmaceutical company specialising in applying deuterium chemistry to known molecules to create novel therapies with improved safety and efficacy profiles
Teva, Sun Pharma to pay Pfizer $2.15 bn to settle patent suit
12 Jun 2013
Teva, the world’s largest generic drug firm, will pay $1.6 billion of the settlement amount while Sun Pharmaceuticals will pay the remaining $550 million
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation